Bionano Genomics, Inc. — Director's Dealing 2018

Aug 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioNano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2018-08-23

Reporting Person: Holmlin R. Erik (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-23	Common Stock	P	1630	$6.125	Acquired	1630	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-23	Common Stock Warrants (right to buy)	$6.125	P	1630	Acquired	2023-08-21	Common Stock (1630)	Direct

Footnotes

F1: Units purchased in the Issuer's Initial Public Offering for $6.125 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock.

F2: 9/21/18 or such earlier date as Roth Capital Partners LLC, as representative of the underwriters in the Company's Initial Public Offering, shall determine.